Stay updated on CDX-0159 in Prurigo Nodularis Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 in Prurigo Nodularis Clinical Trial page.

Latest updates to the CDX-0159 in Prurigo Nodularis Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.4.2 was added to the page, and the previous notice (Revision: v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check8 days agoChange DetectedA site-wide notice about a lapse in government funding and potential delays is now shown on the page. The page revision has been updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check15 days agoChange DetectedUI and metadata tweaks include displaying the glossary option and updating QC-related labels and revision text. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page shows a new revision tag, updating from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded a consolidated Locations section listing study sites across multiple states (Arizona, Florida, Michigan, New Mexico, New York, Oklahoma, Texas). Removed the prior state-specific location subsections (Arizona Locations, Florida Locations, Michigan Locations, New Mexico Locations, New York Locations, Oklahoma Locations, Texas Locations) and the HHS Vulnerability Disclosure link.SummaryDifference0.9%

- Check72 days agoChange DetectedThe page shows a minor site revision update from v3.3.1 to v3.3.2; there are no changes to core study content, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CDX-0159 in Prurigo Nodularis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 in Prurigo Nodularis Clinical Trial page.